Overview and Utilization of the NCI Thesaurus by Fragoso, Gilberto et al.
Comparative and Functional Genomics
Comp Funct Genom 2004; 5: 648–654.
Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/cfg.445
Conference Paper
Overview and utilization of the
NCI Thesaurus#
Gilberto Fragoso1*, Sherri de Coronado1, Margaret Haber2, Frank Hartel1 and Larry Wright2
1NCI Center for Bioinformatics, 6116 Executive Blvd, Ste 403, National Cancer Institute, NIH, Bethesda, MD 20892, USA
2NCI Ofﬁce of Communications, 6116 Executive Blvd, National Cancer Institute, NIH, Bethesda, MD 20892, USA
*Correspondence to:
Gilberto Fragoso, NCI Center for
Bioinformatics, 6116 Executive
Blvd, Ste 403, National Cancer
Institute, NIH, Bethesda, MD
20892, USA.
E-mail: fragosog@mail.nih.gov
#This article is a U.S.
Government work and is in the
public domain in the U.S.A.
Received: 21 November 2004
Accepted: 24 November 2004
Abstract
The NCI Thesaurus is a reference terminology covering areas of basic and clinical
science, built with the goal of facilitating translational research in cancer. It contains
nearly 110000 terms in approximately 36000 concepts, partitioned in 20 sub-
domains, which include diseases, drugs, anatomy, genes, gene products, techniques,
and biological processes, among others, all with a cancer-centric focus in content, and
originally designed to support coding activities across the National Cancer Institute.
Each concept represents a unit of meaning and contains a number of annotations, such
as synonyms and preferred name, as well as annotations such as textual deﬁnitions
and optional references to external authorities. In addition, concepts are modelled
with description logic (DL) and deﬁned by their relationships to other concepts;
there are currently approximately 90 types of named relations declared in the
terminology. The NCI Thesaurus is produced by the Enterprise Vocabulary Services
project, a collaborative effort between the NCI Center for Bioinformatics and the
NCI Ofﬁce of Communications, and is part of the caCORE infrastructure stack
(http://ncicb.nci.nih.gov/NCICB/core). It can be accessed programmatically through
the open caBIO API and browsed via the web (http://nciterms.nci.nih.gov). A history
of editing changes is also accessible through the API. In addition, the Thesaurus is
available for download in various ﬁle formats, including OWL, the web ontology
language, to facilitate its utilization by others. Published in 2005 by John Wiley &
Sons, Ltd.
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Introduction
The NCI Thesaurus is a terminology developed
and published by the Enterprise Vocabulary Ser-
vices (EVS) project, a collaborative effort between
the National Cancer Institute’s (NCI) Ofﬁce of
Communications and the NCI Center for Bioinfor-
matics (NCICB). It arose out of the need to have
an institute-wide common terminology in order to
integrate the diverse data systems in use throughout
the NCI [10]. Coding of research-related activi-
ties helped to meet various responsibilities of the
Institute; however, having codes assigned indepen-
dently by various components of the NCI made
it difﬁcult to ﬁnd and combine related informa-
tion across programs. By incorporating the terms
in use by the various programs and mapping them
to unique concepts, it was intended that the NCI
Thesaurus would facilitate interoperability and data
sharing by the various components of the NCI. Its
use within the institute has been expanded as part
of the caCORE infrastructure being developed at
the NCICB [5], where it is utilized as a source
of base semantics and relations, in addition to its
function as a source of codes for data annotation.
The NCI Thesaurus covers clinical and basic
sciences as well as administrative areas. Although
the content is cancer-centric, cancer research spans
a broad area of biology, hence the Thesaurus can
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potentially be utilized outside the cancer research
community. In this paper, we describe the NCI
Thesaurus with the goal of helping researchers and
organizations outside the NCI determine whether
and how to utilize the Thesaurus. We offer an
overview of the content areas in the terminology,
including the various annotations with which the
concepts are tagged, as well as the variety of roles
that relate concepts in different domains. We also
describe how two typical applications are utilizing
the NCI Thesaurus.
Production cycle
The production cycle of the NCI Thesaurus is
described in detail elsewhere [6]. Brieﬂy, the devel-
opment baseline of the Thesaurus is edited in the
Terminology Development Environment suite of
tools from Apelon Inc. (Ridgeﬁeld, CT). Each edi-
tor modiﬁes his/her own database schema con-
taining the terminology and periodically submits
changesets to a workﬂow manager, who reconciles
conﬂicts and generates and distributes new vocabu-
lary baselines to each editor. The workﬂow process
is based on the collaborative terminology develop-
ment model (described in [2,3]). Editing history is
processed in parallel when the baseline is slated for
promotion to production [8]. Production baselines
are published monthly in the Distributed Terminol-
ogy Server (DTS), also from Apelon, and processed
for distribution in Ontylog XML, the native format
supported by the Apelon software, as well as in
OWL [6,12] and ﬂat ﬁle formats. Computer pro-
grams can access the Thesaurus in the DTS through
the caBIO API [5]. Some metrics for the 04.11C
(November, 2004) version of the vocabulary are
shown in Tables 1 and 3.
Structure of concepts
The basic unit of meaning in the NCI Thesaurus
is the concept. A concept is denoted by a name
and a code, and it must have a kind (see below for
an explanation of kinds). Concepts are annotated
with properties (name value pairs), and modelled
in the Ontylog description logic (DL; see [7] for
the semantics of Ontylog).
Roughly, properties in the Thesaurus are uti-
lized to clarify concept meaning, either directly
Table 1. Counts of various entities in the NCI Thesaurus
Thesaurus entity Count
Kinds 20
Properties 44
Roles 91
Concepts 36364
Deﬁned concepts 3960
Terms 107672
Concept w/deﬁnitions 17129
The contribution from retired concepts has not been taken into
account. The value for Terms is taken from the FULL SYN property.
The value for concepts with deﬁnitions (last row) indicates the
number of concepts with at least one deﬁnition; additional deﬁnitions
per concept are not taken into account.
with information we generate/collect or indi-
rectly through references to external authorities,
and to support operations of dependent appli-
cations. In order to facilitate the correct cod-
ing of data in repositories, concepts are anno-
tated with synonyms, textual deﬁnitions, refer-
ences to external authorities, and various other
pieces of information as deemed relevant for a
particular domain. A full listing of the proper-
ties utilized in the Thesaurus can be found in
ftp://ftp1.nci.nih.gov/pub/cacore/EVS/Thesaur-
usSemantics/Properties.pdf
The bulk of the content represented by prop-
erties in the Thesaurus involves terminology. All
the terms associated with a concept are found
in the FULL SYN and Synonym properties. Both
properties contain the same set of terms; how-
ever, the FULL SYN contains additional informa-
tion about the term, such as the term type and
its source. One of the terms found in FULL SYN
is selected as the Preferred Name and it is this
term that is displayed by dependent applications
to users; the Display Name is utilized by applica-
tions when an alternative display term is required.
Properties such as DEFINITION and DesignNote
contain textual descriptions and additional clari-
ﬁcations on the recommended usage of the con-
cept. When possible, references to external author-
ities are included, in properties such as Swiss-Prot
and CAS Registry (in the gene product and drug
domains, respectively), as well as to NCI resources
(e.g. NSC Code). Many of the concepts also have
references to UMLS CUIs (concept-unique identi-
ﬁers assigned by the National Library of Medicine
[11]), as mapped in the NCI MetaThesaurus
(http://ncimeta.nci.nih.gov). Some properties are
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Table 2. Roles instantiated in the disease domain of the Thesaurus in
role expressions, showing the role names and the range kind of the
roles
Role name Range kind
Disease Excludes Abnormal Cell Abnormal Cell Kind
Disease Has Abnormal Cell Abnormal Cell Kind
Disease May Have Abnormal Cell Abnormal Cell Kind
Disease Excludes Normal Cell Origin Anatomy Kind
Disease Excludes Primary Anatomic Site Anatomy Kind
Disease Has Associated Anatomic Site Anatomy Kind
Disease Has Metastatic Anatomic Site Anatomy Kind
Disease Has Normal Cell Origin Anatomy Kind
Disease Has Normal Tissue Origin Anatomy Kind
Disease Has Primary Anatomic Site Anatomy Kind
Disease May Have Normal Cell Origin Anatomy Kind
Disease May Have Normal Tissue Origin Anatomy Kind
Disease Excludes Finding Findings and Disorders Kind
Disease Has Associated Disease Findings and Disorders Kind
Disease Has Finding Findings and Disorders Kind
Disease May Have Associated Disease Findings and Disorders Kind
Disease May Have Finding Findings and Disorders Kind
Disease Excludes Cytogenetic Abnormality Molecular Abnormality Kind
Disease Excludes Molecular Abnormality Molecular Abnormality Kind
Disease Has Cytogenetic Abnormality Molecular Abnormality Kind
Disease Has Molecular Abnormality Molecular Abnormality Kind
Disease May Have Cytogenetic Abnormality Molecular Abnormality Kind
Disease May Have Molecular Abnormality Molecular Abnormality Kind
Disease Is Grade Properties or Attributes Kind
Disease is Stage Properties or Attributes Kind
Table 3. Breakdown of some metrics by domain in the Thesaurus
Kind name Concepts
Concepts with
asserted roles
Roles
asserted
Deﬁned
concepts
Abnormal Cell Kind 553
Anatomy Kind 5079 2692 2805
Biological Process Kind 1010 312 572
Chemicals and Drugs Kind 3589 246 1196
Chemotherapy Regimen Kind 3168 3166 10046
Clinical or Research Activity Kind 1240
Diagnostic and Prognostic Factors Kind 36
EO Anatomy Kind 302
EO Findings and Disorders Kind 1079 230 274
Equipment Kind 100
Findings and Disorders Kind 10417 2264 5856 909
Gene Kind 1963 1909 10497 1533
Gene Product Kind 2324 2073 13522 1518
Molecular Abnormality Kind 574
NCI Kind 2729 237 237
Organism Kind 449
Pathway Kind 442
Properties or Attributes Kind 908
Retired Kind 2558
Technique Kind 402 15 19
Total (-Retired) 36364 13144 45024 3960
The values in the last row represent the total counts per category. The values in columns three and four (denoted by
the ‘Roles’ term in the column header) represent the roles directly asserted on concepts by editors; role inheritance is
not taken into account.
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utilized to express relations between concepts that
we cannot represent in roles (see below) — such
as Gene Encodes Product — because of classiﬁca-
tion cycles, or because a proper representation in
a role has not yet been decided on, or because the
information is perhaps too volatile. Other properties
are intended to be used internally by the EVS, sup-
port legacy applications not yet fully utilizing the
Thesaurus, or mapping to vocabularies required by
other NCI programs (e.g. Related MedDRA Code).
As mentioned above, the terminology is being
developed in a DL environment, so concepts are
compositionally deﬁned by their placement in a
subsumption hierarchy and the role expressions
that are asserted on each. DL is utilized in an
effort to make the classiﬁcation hierarchies in
the terminology more consistent and information
retrieval more accurate. Not all domains have been
fully modelled in DL as of this writing, and some
domains will have little, if any, modelling, as they
are considered reference domains that the main
content areas are modelled against. Our initial
consideration for selecting roles to model any given
domain or kind in the terminology follows the
criteria that roles can be reproducibly applied by
independent domain experts, and can serve a useful
purpose in the terminology [1]. In addition, we
name them so their intent is understandable [1]. In
this initial stage, we normally select the minimal
number of roles that will allow for concepts to
be declared as deﬁned, and give preference to
those roles that can be applied throughout the
entire kind, not just to a sub-domain within the
kind. However, users of the Thesaurus frequently
provide use cases for additional role relations in the
terminology, and sub-domain independence ceases
to be a consideration; the method we have adopted
to help us extend the terminology in such instances
is described elsewhere [7].
Role assertions provide detailed semantic rela-
tionships between domains, e.g. between neoplas-
tic diseases and genes, that can be leveraged by
dependent applications without resorting to DL rea-
soners. However, we cannot view role expressions
as unconstrained semantic relationships to be uti-
lized by users to ﬁnd related information about
an entity, as this can be in conﬂict with the for-
mal utilization of roles in the DL. The support of
non-deﬁning associations by Ontylog in the near
future will allow us to include this type of infor-
mation (i.e. annotation of a concept with another
concept) and support a wider range of use cases. As
an illustration of their nature and scope, the roles
instantiated in the disease domain are shown in
Table 2; a full listing of the roles currently declared
in the NCI Thesaurus is available online from
ftp://ftp1.nci.nih.gov/pub/cacore/EVS/Thesaur-
usSemantics/Roles.pdf. Table 2 shows the type of
information that is being captured via role expres-
sions for concepts in the disease domain. It includes
cell types, primary and metastatic anatomical sites,
ﬁndings, associated diseases, and various types of
molecular and cellular abnormalities. Some roles
are considered deﬁnitional for a disease, others are
not, and care is taken that all assertions are valid
for all sub-types.
A summary of the extent of modelling per
kind, as gauged by the number of concepts with
directly asserted role expressions, is shown in
Table 3. Nearly 35% of the concepts have directly
asserted role relations, and many more inherit such
relationships through the classiﬁcation hierarchy.
In the main modelling areas in the Thesaurus, this
value ranges from 20% in the diseases and disorder
kind to nearly 90–95% in the genes and gene
product kinds. Still, the concepts modelled to the
degree that they can be declared deﬁned is roughly
10%, all in the gene, gene products and disease
domains.
Content areas
The NCI Thesaurus contains the terminology in
use by the various divisions and ofﬁces of the
NCI. Its coverage spans administrative, scientiﬁc
and clinical areas, although because of its focus
on cancer, it does not cover each domain exhaus-
tively. In brief, the areas are encoded as kinds in
the Thesaurus, which can be thought of as types or
disjoint classes. Each concept can have only one
kind, although concepts can be placed in multi-
ple locations in the taxonomic trees describing that
kind. The kinds are listed in Table 3; the full list-
ing along with the kind deﬁnitions can be found in
ftp://ftp1.nci.nih.gov/pub/cacore/EVS/Thesaur-
usSemantics/KindDeﬁnitions.pdf.
A number of the kinds consist of trees with sev-
eral upper level branches built on different orga-
nizing principles; while one branch is meant to be
populated with concepts according to that branch’s
organizing principle, the rest of the branches are
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meant to serve as a reference that the main
branch concepts can be modelled against (e.g.
the Protein, Organized by Structure subheading
of Protein). However, in some cases the ancil-
lary branches contain concepts that cannot easily
be placed under the main branch and which are
better described by the alternative view these hier-
archies provide. The non-administrative domain
areas in the Thesaurus include genes, gene prod-
ucts, pathways, biological processes, anatomy, dis-
orders, drugs and combination chemotherapies
(Table 3). These might be of general interest for
either the content or the model. Other, perhaps
more speciﬁc areas, include molecular abnormal-
ities, abnormal cell types, anatomy and disorders
of experimental organisms, techniques and equip-
ment.
The combination chemotherapy area merits men-
tion as a unique, comprehensive resource. Cancer
therapy is largely based on combinations of multi-
ple drugs, and the NCI Thesaurus listing includes
all combinations known to be used in either clini-
cal trials or standard clinical practice. This domain
is largely unstructured in the Thesaurus, and all
the concepts in the domain are primitive (i.e. not
deﬁned in the DL sense), although almost all of
them (about 99%) are related to their component
drugs by role expressions.
The chemical and drug area is subdivided into
structural and functional classiﬁcation branches.
The functional branch contains a number of sub-
areas, such as Pharmacologic Substance, Chemi-
cal Modiﬁer, Reagent and Industrial Product. The
vast majority of concepts in this domain are prim-
itive, and most are organized under Pharmaco-
logic Substance,r e ﬂecting an interest in the uti-
lization of drugs for cancer treatment. A great
deal of work in this kind was initially done in
a separate experimental database, with the goal
of creating a drug model that can be shared
with other US federal agencies and organizations,
including the Veterans Health Administration, the
Food and Drug Administration, and the National
Library of Medicine. Integration and ﬂeshing out
of the drug model in the production version of
the Thesaurus is currently ongoing, and will relate
drugs to molecular entities such as proteins, to
biological processes and physiologic effects, and
to diseases. Additional work on terminology in
the nutrient and chemoprevention areas is also
under way.
The anatomy domain is one of the most gen-
eral in the Thesaurus. It is partitioned into sev-
eral sub-branches spanning gross anatomy through
microanatomy, and includes ﬂuids, cavities and
entities at the molecular level. Constituent parts
of anatomical sites are placed in distinct shal-
low branches built with the is a relation and
related through part of-type role expressions to
the anatomical whole. Although has location roles
have been instantiated, the vast majority of rela-
tions in the present version of the anatomy kind
involve the part of role. The resulting graph pro-
vides a view of the domain that is considered very
useful as a reference kind to model diseases against.
It has been reviewed and recommended for cod-
ing purposes by the Consolidated Health Informat-
ics group [4]. We do not envision major changes
in this domain; however, ongoing analysis in col-
laboration with the Jackson Laboratory and other
interested parties is expected to result in a harmo-
nization of this domain with other terminologies,
including those for mice and other experimental
organisms.
The ﬁndings and disorders kind contains more
than 10000 concepts, including 6500 neoplastic as
well as many non-neoplastic disease concepts of
special interest to the Institute. The top concept
for the neoplastic diseases is Neoplasm, and most
of the concepts in this domain are doubly treed
under both Neoplasm by Morphology and Neo-
plasm by Site subheadings. All neoplasm concepts
have at least some role modelling, with an aver-
age of slightly over 10 roles per concept, largely
based on characteristics inherited through an exten-
sive, multi-faceted classiﬁcation hierarchy. Never-
theless, most of the concepts are still primitive in
the DL sense; modelling in this area is proceed-
ing at a fast pace, with a large effort devoted to
the proper expression of relationships between con-
cepts both within and outside the kind (see above
and Table 2). Partly because of the increasing focus
on molecular signatures of diseases, concepts in
this domain require the largest number of role
expressions before they can be considered deﬁned.
Further, and as mentioned elsewhere, some non-
deﬁning relations convey information considered
useful by clinicians. Because of the terminology
content, as well as the semantic relations, the dis-
ease domain is one of the richest areas in the
Thesaurus.
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The gene kind contains cancer-related genes
organized according to biological function. In addi-
tion to oncogenes and tumour suppressors, this kind
includes genes that are not known to be involved
in oncogenesis; however, they have been added
because, for instance, they might participate in
processes related in some fashion to oncogene-
sis, e.g. cell cycle. This kind is difﬁcult to model
because the main deﬁning characteristic of a gene,
its sequence, does not belong in a terminology.
Nevertheless, the set of relations required to declare
a gene concept deﬁned, which includes pathway,
process and disease associations, can distinguish
between the vast majority of cases; chromosomal
location is usually the only feature that can be used
to distinguish between members of gene families.
Some restructuring of the domain is still deemed
necessary, however.
In terms of content, the gene product kind is very
similar to the gene kind. It contains protein and
RNA products that are either directly related to, or
have some type of association with, oncogenesis.
The concepts are organized by function, but the
domain also contains trees that describe alternative
organizations by location and structure. Because
of the active role of gene products in normal and
abnormal processes, concepts in this domain are
related to a wider number of reference domains
than their reference genes.
The biochemical pathways domain is consid-
ered a reference kind and has been modelled
minimally. It consists of named pathway con-
cepts derived from KEGG [9] and BioCarta
(http://www.biocarta.com/), organized in a sim-
ple shallow hierarchy of general concepts, such as
Metabolic Pathway, Regulatory Pathway and Sig-
naling Pathway. No roles have been declared in this
domain; however, this kind is the range for roles
declared in the gene and gene product domains, e.g.
Gene Product Is Element in Pathway. Although
this area is of great importance, and can serve to
deﬁne genes and gene products, it was not included
in the Thesaurus until recently because of issues
related to naming conventions and the start and
endpoints of pathways. We anticipate some restruc-
turing as the ﬁeld advances.
The biological process domain covers the range
from Subcellular Process through Population Pro-
cess. These disjoint biological areas are spanned
by Pathologic Process. Although broad, the hierar-
chies are not very deep. Our main interest in this
area are the pathological processes, although nor-
mal biological processes must be represented to a
certain extent — in some instances for their termi-
nology, in other instances as a source of role values
used to deﬁne concepts in other domains.
Utilization of the NCI Thesaurus
As mentioned above, the main use for the The-
saurus is to provide codes for annotation of artifacts
in NCI data repositories. Because it is being devel-
oped in DL, dependent applications are also begin-
ning to utilize its semantic relationships to allow
users to navigate between domains. As it can be
accessed freely, the EVS does not collect informa-
tion on its use; however, two examples of appli-
cations utilizing the Thesaurus in the NCICB are
caIMAGE (http://cancerimages.nci.nih.gov/) and
the caDSR (http://ncicb.nci.nih.gov/core/caDSR).
The caIMAGE (cancer Images database) is a
portal application supporting users of the Mouse
Models of Human Cancers Consortium (MMHCC).
Data is coded with anatomical locations as well
as with diseases. When submitting or searching
for speciﬁc images, users are presented with a
tree browser of the anatomy domain, so that they
can select the most speciﬁc concept that represents
the anatomical location of the image. Once a
speciﬁc anatomical system is selected, a second tree
browser is displayed that selects a branch in the
diseases domain with a relation to the anatomical
site already entered. The branch selected for display
is the most speciﬁc that can be returned based
on the relations asserted between domains; if no
relation to a disease has been asserted for a speciﬁc
anatomical concept, the application walks up the
hierarchy and selects the next concept it ﬁnds with
the appropriate relation asserted. This application
helps users to select annotations with the highest
degree of speciﬁcity.
The caDSR (cancer Data Standards Repository)
is an ISO 11179 metadata registry originally devel-
oped to help store and maintain common data ele-
ments utilized in case report forms. Vocabulary for
the metadata is now drawn exclusively from the
vocabularies available through the EVS, mainly the
Thesaurus. The administrative and curation tools
enforce this dependency; if no suitable term is
found by a curator in the Thesaurus when creating
a data element, for instance, the user is required
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to request assistance from EVS editors which, if
necessary, will create a new concept and return its
code, preferred name and a deﬁnition.
Future prospects
The NCI Thesaurus is not a ﬁnished product
and will continue to evolve, hopefully gracefully.
Although it contains terminology already in use in
the NCI, new applications are being developed that
require very often not only the inclusion of addi-
tional concepts and terms, but a speciﬁc set of rela-
tions between concepts. In addition, some changes
might be more signiﬁcant than others. When devel-
oping a new domain area in the Thesaurus (ﬁve
within the last 12 months), it is not always clear
what is the best structure and organization to satisfy
the user requirements; we err on the side of cau-
tion by maintaining these areas in their own kinds
while use cases are reﬁned and our own integra-
tion concerns are addressed. This is an operational
issue; we need to begin serving new terminology
very quickly, yet maintain the ﬂexibility to inte-
grate a new area within the existing structure(s) of
the Thesaurus — our experience has been that it is
easier to integrate kinds than it is to split one into
two disjoint areas. As terminology evolution is to
be expected, concept history tracking and querying
mechanisms should be considered a necessity.
Some areas in the Thesaurus are less speciﬁct o
cancer than others. They provide some basic terms
and concepts, and serve to model against; however,
they still require resources to maintain and enhance
them. We recognize that the ability to integrate
other terminologies into the Thesaurus in a way
that would respect the source’s integrity, as well
as our own operational and editorial constraints,
would allow us to concentrate more on the main
cancer-related content of the Thesaurus. This con-
cern is not restricted to us. A common language for
vocabulary developers, such as OWL, which sup-
ports namespaces, offers prospects in this regard.
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